BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18559518)

  • 1. Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia.
    Mayer A; Höckel M; Wree A; Leo C; Horn LC; Vaupel P
    Cancer Res; 2008 Jun; 68(12):4719-26. PubMed ID: 18559518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-mediated hypoxic response is missing in severely hypoxic uterine leiomyomas.
    Mayer A; Hoeckel M; von Wallbrunn A; Horn LC; Wree A; Vaupel P
    Adv Exp Med Biol; 2010; 662():399-405. PubMed ID: 20204822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
    Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
    Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas.
    Cleven AH; van Engeland M; Wouters BG; de Bruïne AP
    Cell Oncol; 2007; 29(3):229-40. PubMed ID: 17452775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
    Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
    Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking?
    Mayer A; Höckel M; Vaupel P
    Strahlenther Onkol; 2006 Sep; 182(9):501-10. PubMed ID: 16944371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous hypoxia markers: case not proven!
    Mayer A; Höckel M; Vaupel P
    Adv Exp Med Biol; 2008; 614():127-36. PubMed ID: 18290322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.
    Sobhanifar S; Aquino-Parsons C; Stanbridge EJ; Olive P
    Cancer Res; 2005 Aug; 65(16):7259-66. PubMed ID: 16103077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients.
    Nordsmark M; Eriksen JG; Gebski V; Alsner J; Horsman MR; Overgaard J
    Radiother Oncol; 2007 Jun; 83(3):389-97. PubMed ID: 17499868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
    Hutchison GJ; Valentine HR; Loncaster JA; Davidson SE; Hunter RD; Roberts SA; Harris AL; Stratford IJ; Price PM; West CM
    Clin Cancer Res; 2004 Dec; 10(24):8405-12. PubMed ID: 15623619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.
    Kim BW; Cho H; Chung JY; Conway C; Ylaya K; Kim JH; Hewitt SM
    J Transl Med; 2013 Aug; 11():185. PubMed ID: 23927384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro.
    Said HM; Polat B; Staab A; Hagemann C; Stein S; Flentje M; Theobald M; Katzer A; Vordermark D
    Oncol Rep; 2008 Aug; 20(2):413-9. PubMed ID: 18636206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma.
    Sung FL; Hui EP; Tao Q; Li H; Tsui NB; Lo YM; Ma BB; To KF; Harris AL; Chan AT
    Cancer Lett; 2007 Aug; 253(1):74-88. PubMed ID: 17320280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation.
    Jensen R; Lee J
    Neurosurgery; 2012 Jul; 71(1):146-56. PubMed ID: 22472549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastases.
    Rajaganeshan R; Prasad R; Guillou PJ; Scott N; Poston G; Jayne DG
    Eur J Surg Oncol; 2009 Dec; 35(12):1286-94. PubMed ID: 19540709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
    Andersen S; Eilertsen M; Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
    Lung Cancer; 2011 Jun; 72(3):294-302. PubMed ID: 21075472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium.
    Hou P; Zhao L; Li Y; Luo F; Wang S; Song J; Bai J
    Mol Hum Reprod; 2014 Feb; 20(2):148-54. PubMed ID: 24130091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
    Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
    Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.